She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a wel...

Aurevia

Ozempic may benefit hip replacement surgery

The high-profile drug for type 2 diabetes and weight loss may be beneficial in other areas. One such area is for patients undergoing hip replacement surgery, a new study suggests....

Ny motgång för Pfizers satsning inom obesitas

Pfizers ambitioner inom obesitas har fått sig en ny törn. Nu lägger bolaget ner ännu ett GLP-1-projekt.

Assignment: Facilitate the retention of foreign researchers

A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.

MSD discontinues development of cancer drugs after trial failures

MSD suspends Phase 3 trials for two drug programs for different forms of cancer after trial failures.

GSK pays 2.2 billion dollars to settle Zantac lawsuits

British drugmaker Glaxo Smith Kline, GSK, has struck a 2.2 billion dollar settlement, thereby resolving a vast majority of the liability cases pending against t...

"Are we doing business the wrong way around in the Life Science Sector?"

For the past 50 years we have created solutions for problems that we thought would solve the problems. Pharmaceuticals have created big block buster drugs which...

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Klartecken för första läkemedlet mot lungsjukdomen NCFBE – väntas bli en blockbuster

Det första läkemedlet i en helt ny klass, DPP1-hämmare, har godkänts i USA. Det är det första sjukdomsmodifierande läkemedlet mot bronkiektasier utan cystisk fi...

Texas stämmer Eli Lilly för påstådda mutor mot vårdgivare

Eli Lilly stäms av delstaten Texas efter anklagelser om att den amerikanska läkemedelsjätten mutat vårdgivare att skriva ut bolagets läkemedel.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Anders Blanck about his 17 years at Lif: “The industry is enjoying greater public trust now"

The announcement came as a surprise to those around him, but according to the protagonist himself, the timing was excellent. Anders Blanck is now leaving Lif – ...

Pfizer licensierar kinesisk cancerkandidat

Amerikanska Pfizer kommer få tillgång en experimentell cancerbehandling från kinesiska 3SBio genom ett nytecknat licensavtal.

Nytt misslyckande för Pfizer inom blodsjukdom

För andra gången på mindre än ett år har Pfizer drabbats av en tung motgång för sin ambition att ta fram ett effektivt läkemedel för sicklecellssjukdom. Denna g...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

New drug alert in the US: Rise in overdoses linked to the use of drugs for animals

A combination of the synthetic drugs fentanyl and xylazine, an animal tranquilizer, has been labelled a “growing threat” by the White House due to its role in t...

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Lovande resultat för Lillys fetmapiller – skapar börsvågor

Eli Lillys viktminskningspiller överträffar förväntningarna i en fas III-studie och visar resultat i nivå med injicerbara läkemedel som Ozempic. Nyheten fick ak...

Mångmiljardaffär i jakten på nästa blockbuster inom cancer

Bristol Myers Squibb betalar upp till 11,1 miljarder dollar, motsvarande 106 miljarder kronor, för att köpa in sig i en av de hetaste läkemedelskandidaterna inom immunonkologi.

Nytt stort labbhus i Lund invigt – här är bolagen som flyttar in

Medicon Village har fått en ny laboratoriebyggnad. I dag invigdes huset med bandklippning av arbetsmarknads- och integrationsminister Mats Persson (L) och bygge...

“We need to keep investing in research and innovation”

Jenni Nordborg has worked for just over four years to highlight life science in Sweden. Her mandate as national coordinator ends in December 2022. ““Life scienc...

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.

Enabling 3D Multiplexing Spatial Omics Workflows in Neuroscience

Case study by ZEISS Microscopy.